Yesterday, I attended a half day symposium on companion diagnostics (CDx) efforts in San Diego which was organized by the SABPA Science & Technology Forum. CDx is the identification and detection of biomarkers to predict whether a drug will work or not in a given patient. Two successful marketed products are HercepTest (marketed by Dako) for Herceptin and KRAS tests for Erbitux and Vectibix. San Diego biotech has a rich history and deep investments in diagnostics. This was reflected in the lineup of various talks.
Oncology targets, strategies, cancer drug development and personalized medicine
Sunday, March 20, 2011
Monday, March 14, 2011
2011 Japan Earthquake and Tsunami - Help Bring Sendai Back to its Former Self
It is Spring in the Prairies and lovely Fall in Patagonia, and while the world goes through the simple beauty of seasons, one corner of the earth, in the coastal north Japan, has seen countless lives of its citizens shattered and those of survivors changed for ever.
Thursday, March 3, 2011
Helping Win Steve Jobs' Pancreatic Cancer Fight For All of US Because iPads Are Not the Only Things That Matter
Yesterday, Steve Jobs once again returned to the world stage to introduce Apple's new iPad2 and once again the spotlight was also put on his ongoing battle with pancreatic cancer.
Subscribe to:
Posts (Atom)